Giant Biogene Holding Co. Ltd., China’s largest supplier of collagen-based skincare products, has filed for an IPO in Hong Kong, adding to a growing list of Chinese companies trying to tap global capital through the financial hub as they face increasingly troubled Problems shy away from US listings.
The company filed its prospectus with Hong Kong Exchanges & Clearing Ltd on Thursday. (HKEX) and announced that its revenue has grown for three consecutive years, growing by almost two-thirds to 1.55 billion yuan (US$232.5 million) in the year, from 956.7 million yuan in 2021 2019
You have accessed an article that is only available to subscribers
Comments are closed.